Skip to main content
. 2017 Feb 22;9(4):615–627. doi: 10.1080/19420862.2017.1290752

Table 1.

Anti-STn mAb binding results summary.

    ELISA EC50 (nM)
Glycan Array
  Internalization
mAb Isotype BSM1 OSM2 PSM3 (%)4 Binding Group5 FACS EC50 (nM)MDA-MB-231 STn+ Mean FI p-value
8C2–2D6 IgG2a,k 0.4 0.5 0.3 99 1 2.8 7.6 0.03
2G12–2B2 IgG2a,k 0.1 0.1 0.1 99 1 0.3 6.7 0.01
4G8–1E3 IgG2a,k 1.2 0.6 0.1 99 1 0.7 7.4 0.01
S3F* IgG2a,k 0.3 0.1 0.2 98 1 3.1 8.1 0.001
5G2–1B3 IgG1,k 0.4 0.2 10.2 92 4 0.2 ND ND
2C2–2C5 IgG3,k 1 0.2 0.2 100 1 0.8 6.2 0.03
5E6–2E7 IgG3,k 5.8 0.8 0.4 100 1 1.8 7.5 0.04
9F11–1F7 IgG3,k 4.6 0.9 0.9 99 1 0.8 5.5 0.05

Summary Table of binding results.

1

BSM is bovine submaxillary mucin.

2

PSM is Porcine Submaxillary Mucin.

3

OSM is ovine submaxillary mucin.

4

% signal on the glycan array; the higher the percentage the more STn specific the antibody.

5

The binding group see Fig. 1. ND is not determined. ELISA EC50s were determined after subtracting signal from periodate treated wells from non-treated wells.

*

S3F was not generated during our immunizations – this is derived from HB-STn clone 3F1. We class switched from mouse IgG1 and recombinantly expressed as a mouse IgG2a, we refer to this engineered antibody as “S3F” in the text.